Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions

Figure 3 Melatonin reduced cisplatin-induced intracellular reactive oxygen species levels. Hepatocellular carcinoma cells were treated with melatonin (1 mmol/L) and/or cisplatin (20 μmol/L) for 24 h. The results are presented as the means ± SE. (^cP < 0.001 compared with the control group, ^dP < 0.05 compared with the cisplatin-treated group).